Key Takeaways From ADMA Biologics Analyst Ratings
Key Takeaways From ADMA Biologics Analyst Ratings
adma生物製品分析師評級的主要觀點
The perception of...Throughout the last three months, 4 analysts have evaluated ADMA Biologics (NASDAQ:ADMA), offering a diverse set of opinions from bullish to bearish.
過去三個月來，有4位分析師對adma biologics（納斯達克：ADMA）進行了評估，提出了從看好到看淡的不同意見。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.0, a high estimate of $20.00, and a low estimate of $18.00. Witnessing a positive shift, the current average has risen by 20.63% from the previous average price target of $15.75.
分析師評估的12個月價格目標揭示了更多見解，平均目標爲19.0美元，最高估值爲20.00美元，最低估值爲18.00美元。目前的平均值已經上升了20.63%，從之前的15.75美元的平均價格目標。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
The perception of...
通過最...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間